Yellow Fever Virus Vaccine and Immune Globulin Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00254826

Recruitment Status : Completed

First Posted : November 17, 2005

Last Update Posted : December 4, 2013

Sponsor:

Collaborators:

Sanofi Pasteur, a Sanofi Company

Centers for Disease Control and Prevention

Information provided by (Responsible Party):

Mark Mulligan, Emory University

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	November 2008
Actual Study Completion Date :	November 2008

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Edupuganti S, Eidex RB, Keyserling H, Akondy RS, Lanciotti R, Orenstein W, del Rio C, Pan Y, Querec T, Lipman H, Barrett A, Ahmed R, Teuwen D, Cetron M, Mulligan MJ; YF-Ig Study Team. A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity. Am J Trop Med Hyg. 2013 Jan;88(1):172-7. doi: 10.4269/ajtmh.2012.12-0179. Epub 2012 Dec 3.

To Top